Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $827.66 | 92 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $400.33 | 51 | $0 (2022) |
| ABBVIE INC. | $285.14 | 29 | $0 (2024) |
| Novo Nordisk Inc | $38.92 | 3 | $0 (2022) |
| GlaxoSmithKline, LLC. | $27.85 | 2 | $0 (2022) |
| Lilly USA, LLC | $16.40 | 1 | $0 (2021) |
| Biohaven Pharmaceutical Holding Company Ltd. | $14.82 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $14.04 | 1 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $12.98 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $11.80 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $46.54 | 3 | ABBVIE INC. ($46.54) |
| 2023 | $17.69 | 1 | ABBVIE INC. ($17.69) |
| 2022 | $323.43 | 34 | Janssen Pharmaceuticals, Inc ($211.31) |
| 2021 | $440.00 | 54 | Janssen Pharmaceuticals, Inc ($189.02) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: NEUROSCIENCE | ||||||
| 01/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/11/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: RESPIRATORY | ||||||
| 07/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/03/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: PRIMARY CARE | ||||||
| 05/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/18/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: Diabetes | ||||||
| 05/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/06/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/04/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEUROSCIENCE | ||||||
| 04/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: NEUROSCIENCE | ||||||
| 04/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.84 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/30/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/21/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/17/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $1.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 200 | 347 | $54,632 | $17,418 |
| 2022 | 22 | 1,411 | 1,958 | $146,622 | $46,517 |
| 2021 | 27 | 2,100 | 3,334 | $232,388 | $82,327 |
| 2020 | 30 | 1,695 | 2,558 | $183,755 | $55,866 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 74 | 218 | $38,382 | $11,956 | 31.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 41 | 41 | $10,660 | $4,259 | 40.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 16 | $2,350 | $665.63 | 28.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 39 | 39 | $1,755 | $291.33 | 16.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 33 | 33 | $1,485 | $246.51 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 211 | 421 | $82,957 | $24,557 | 29.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 21 | $9,228 | $3,577 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 33 | 33 | $6,160 | $3,481 | 56.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 114 | 137 | $6,261 | $2,276 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 55 | $7,502 | $2,184 | 29.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 111 | 145 | $3,317 | $1,517 | 45.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 97 | 108 | $3,322 | $1,429 | 43.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 28 | 30 | $1,350 | $1,229 | 91.1% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 110 | 131 | $3,255 | $1,171 | 36.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 114 | 143 | $2,987 | $1,080 | 36.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 64 | 89 | $2,381 | $834.27 | 35.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 36 | 55 | $2,035 | $602.38 | 29.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 132 | 192 | $3,443 | $569.40 | 16.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 50 | 79 | $3,713 | $560.73 | 15.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 12 | 24 | $744.00 | $393.24 | 52.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 23 | 23 | $1,150 | $341.11 | 29.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 22 | 22 | $550.00 | $320.15 | 58.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 108 | 131 | $785.00 | $290.65 | 37.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2022 | 12 | 13 | $182.00 | $66.49 | 36.5% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 13 | 24 | $360.00 | $21.29 | 5.9% |
About Melba Massie, PA
Melba Massie, PA is a Physician Assistant healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235161902.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melba Massie, PA has received a total of $827.66 in payments from pharmaceutical and medical device companies, with $46.54 received in 2024. These payments were reported across 92 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($827.66).
As a Medicare-enrolled provider, Massie has provided services to 5,406 Medicare beneficiaries, totaling 8,197 services with total Medicare billing of $202,128. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Ashland, KY
- Active Since 07/06/2006
- Last Updated 09/06/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1235161902
Products in Payments
- XARELTO (Drug) $400.33
- VRAYLAR (Drug) $232.35
- UBRELVY (Drug) $52.79
- Rybelsus (Drug) $27.73
- TRULICITY (Drug) $16.40
- ANORO ELLIPTA (Drug) $15.90
- NURTEC ODT (Drug) $14.82
- FARXIGA (Drug) $14.04
- ENTRESTO (Drug) $12.98
- TRELEGY ELLIPTA (Drug) $11.95
- BELSOMRA (Drug) $11.80
- Ozempic (Drug) $11.19
- Xofluza (Drug) $5.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Ashland
Sara Everman, Pa-C, PA-C
Physician Assistant — Payments: $9,080
Gregory Moore, Pa-C, PA-C
Physician Assistant — Payments: $4,271
Dustin Adkins, Pa, PA
Physician Assistant — Payments: $3,623
Lindsay Montgomery, Pa-C, PA-C
Physician Assistant — Payments: $3,586
Angela Pannuti, Pa-C, PA-C
Physician Assistant — Payments: $3,068
Deann Brown, Pa-C, Caq-Psych, PA-C, CAQ-PSYCH
Physician Assistant — Payments: $2,989